Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zheng-Chi Lee"'
Autor:
Marco Hadisurya, Li Li, Kananart Kuwaranancharoen, Xiaofeng Wu, Zheng-Chi Lee, Roy N. Alcalay, Shalini Padmanabhan, W. Andy Tao, Anton Iliuk
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-19 (2023)
Abstract Background Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been recognized as genetic risk factors for Parkinson’s disease (PD). However, compared to cancer, fewer genetic mutations contribute to the cause of PD, propelling
Externí odkaz:
https://doaj.org/article/bb715f3f213548718f0eb37825217e71
Autor:
Marco Hadisurya, Zheng-Chi Lee, Zhuojun Luo, Guiyuan Zhang, Yajie Ding, Hao Zhang, Anton B. Iliuk, Roberto Pili, Ronald S. Boris, W. Andy Tao
Publikováno v:
Molecular & Cellular Proteomics. 22:100536
Translating the research capability and knowledge in cancer signaling into clinical settings has been slow and ineffective. Recently, extracellular vesicles (EVs) have emerged as a promising source for developing disease phosphoprotein markers to mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7a61303845d24b4f42f6c6a97584c0
https://doi.org/10.1016/j.mcpro.2023.100536
https://doi.org/10.1016/j.mcpro.2023.100536
Autor:
Marco Hadisurya, Li Li, Kananart Kuwaranancharoen, Xiaofeng Wu, Zheng-Chi Lee, Roy N. Alcalay, Shalini Padmanabhan, W. Andy Tao, Anton Iliuk
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been recognized as genetic risk factors for both familial and sporadic forms of Parkinson’s disease (PD). However, compared to cancer, overall lower genetic mutations contribute to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ba61944b85e76e6bc083b3b3fdcea74
https://doi.org/10.1101/2022.01.18.22269096
https://doi.org/10.1101/2022.01.18.22269096
